Agreements reached under this partnership
Capital and Business Alliance- 1
Provide financial support for Ember LifeSciences' technology development and business expansion through an investment in the company
- 2
Acquire exclusive distribution rights in Japan's healthcare sector for solutions such as Ember Cube provided by Ember LifeSciences
- 3
Conduct sales activities, customer management and relationship-building with logistics companies by leveraging Alfresa's nationwide pharmaceutical distribution network
- 4
Provide a stable supply of Ember Cube and other products, as well as the provision, maintenance and updating of related systems and technical, marketing and other support
These are items that the documents state the two companies will work on. The lines above and below represent arrangements between the two companies.
The impact of this transaction on performance for the current fiscal year is expected to be immaterial, but the Company believes it will contribute to enhancing the corporate value of the Group over the medium to long term.
| Item | Details |
|---|---|
| Name of alliance partner | Ember LifeSciences, Inc. |
| Alliance partner's business activities | Development and provision of cold-chain technologies for the healthcare and pharmaceutical sectors, including self-cooling, cloud-connected delivery boxes such as Ember Cube for transporting temperature-sensitive pharmaceuticals and vaccines |
| Alliance partner's location | Westlake Village, California, United States |
| Type of alliance | Capital and Business Alliance |
| Details of the alliance | Provide financial support for Ember LifeSciences' technology development and business expansion through an investment in the company, Acquire exclusive distribution rights in Japan's healthcare sector for solutions such as Ember Cube provided by Ember LifeSciences, Conduct sales activities, customer management and relationship-building with logistics companies by leveraging Alfresa's nationwide pharmaceutical distribution network, Provide a stable supply of Ember Cube and other products, as well as the provision, maintenance and updating of related systems and technical, marketing and other support |
| Contract Date | Business alliance agreement date: 25 June 2026; capital alliance agreement date: 1 July 2026 |
| Impact on Business Performance | The impact of this transaction on performance for the current fiscal year is expected to be immaterial, but the Company believes it will contribute to enhancing the corporate value of the Group over the medium to long term. |
Items this document does not state (16)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Ensuring quality across the entire pharmaceutical cold chain, including the last mile, has become increasingly important as specialty pharmaceuticals become more prevalent and home healthcare expands. The alliance will also enhance the Alfresa Group's total supply chain service capabilities.